Results
|
1601.
|
|
|
1602.
|
|
|
1603.
|
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. [electronic resource] by
- Luna, Gustavo
- Alping, Peter
- Burman, Joachim
- Fink, Katharina
- Fogdell-Hahn, Anna
- Gunnarsson, Martin
- Hillert, Jan
- Langer-Gould, Annette
- Lycke, Jan
- Nilsson, Petra
- Salzer, Jonatan
- Svenningsson, Anders
- Vrethem, Magnus
- Olsson, Tomas
- Piehl, Fredrik
- Frisell, Thomas
Producer: 20201117
In:
JAMA neurology vol. 77
Availability: No items available.
|
|
1604.
|
|
|
1605.
|
|
|
1606.
|
|
|
1607.
|
|
|
1608.
|
|
|
1609.
|
|
|
1610.
|
|
|
1611.
|
|
|
1612.
|
|
|
1613.
|
|
|
1614.
|
|
|
1615.
|
|
|
1616.
|
|
|
1617.
|
|
|
1618.
|
|
|
1619.
|
|
|
1620.
|
|